CY1110998T1 - Θεραπεια βακτηριακων ασθενειων των αναπνευστικων οργανων με τοπικη εφαρμογη φθοροκινολονων - Google Patents

Θεραπεια βακτηριακων ασθενειων των αναπνευστικων οργανων με τοπικη εφαρμογη φθοροκινολονων

Info

Publication number
CY1110998T1
CY1110998T1 CY20101101161T CY101101161T CY1110998T1 CY 1110998 T1 CY1110998 T1 CY 1110998T1 CY 20101101161 T CY20101101161 T CY 20101101161T CY 101101161 T CY101101161 T CY 101101161T CY 1110998 T1 CY1110998 T1 CY 1110998T1
Authority
CY
Cyprus
Prior art keywords
respiratory
fluorocinolones
institutions
local application
bacterial diseases
Prior art date
Application number
CY20101101161T
Other languages
English (en)
Inventor
Rainer Endermann
Harald Labischinski
Christoph Ladel
Uwe Petersen
Ben Newton
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32851853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110998(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10305318A external-priority patent/DE10305318A1/de
Priority claimed from DE10305319A external-priority patent/DE10305319A1/de
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of CY1110998T1 publication Critical patent/CY1110998T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η εφεύρεση αφορά εισπνεύσιμες συνθέσεις παραγώγων κινολονοκαρβοξυλικού οξέος για την τοπική καταπολέμηση ασθενειών των αναπνευστικών οργάνων, ιδιαιτέρως πνευμονικών ασθενειών.
CY20101101161T 2003-02-10 2010-12-17 Θεραπεια βακτηριακων ασθενειων των αναπνευστικων οργανων με τοπικη εφαρμογη φθοροκινολονων CY1110998T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10305318A DE10305318A1 (de) 2003-02-10 2003-02-10 Behandlung bakteriell verursachter Lungenkrankheiten
DE10305319A DE10305319A1 (de) 2003-02-10 2003-02-10 Behandlung bakteriell verursachter Lungenkrankheiten
EP04705765A EP1594500B1 (de) 2003-02-10 2004-01-28 Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen

Publications (1)

Publication Number Publication Date
CY1110998T1 true CY1110998T1 (el) 2015-06-11

Family

ID=32851853

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101161T CY1110998T1 (el) 2003-02-10 2010-12-17 Θεραπεια βακτηριακων ασθενειων των αναπνευστικων οργανων με τοπικη εφαρμογη φθοροκινολονων

Country Status (28)

Country Link
US (2) US8034817B2 (el)
EP (1) EP1594500B1 (el)
JP (2) JP4828405B2 (el)
KR (1) KR101173696B1 (el)
AR (1) AR043117A1 (el)
AT (1) ATE482706T1 (el)
AU (1) AU2004210399B2 (el)
BR (1) BRPI0407368A (el)
CA (1) CA2515262C (el)
CY (1) CY1110998T1 (el)
DE (1) DE502004011696D1 (el)
DK (1) DK1594500T3 (el)
EC (1) ECSP055959A (el)
HK (1) HK1089380A1 (el)
HR (1) HRP20050786B1 (el)
IL (1) IL170027A (el)
MA (1) MA27632A1 (el)
MX (1) MXPA05008407A (el)
MY (1) MY144714A (el)
NO (1) NO331524B1 (el)
NZ (1) NZ541681A (el)
PE (1) PE20050189A1 (el)
PT (1) PT1594500E (el)
RU (1) RU2373937C9 (el)
SI (1) SI1594500T1 (el)
TW (1) TWI347843B (el)
UY (1) UY28179A1 (el)
WO (1) WO2004069253A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0407368A (pt) * 2003-02-10 2006-02-14 Bayer Healthcare Ag tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.
US7157455B2 (en) * 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives
WO2006033713A2 (en) * 2004-08-09 2006-03-30 Chiron Corporation Methods for ciprofloxacin inhalation
EP1809252A2 (en) * 2004-10-29 2007-07-25 Presidents and Fellows of Harvard College Particles for treatment of pulmonary infection
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PT1901749T (pt) * 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Fluoroquinolonas aerossolizadas e suas utilizações
MX2010012452A (es) 2008-05-15 2011-03-15 Novartis Ag Star Suministro pulmonar de una fluoro-quinolona.
MX345158B (es) 2008-10-07 2017-01-18 Raptor Pharmaceuticals Inc Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
HUE050147T2 (hu) 2008-10-07 2020-11-30 Horizon Orphan Llc Tüdõgyulladás csökkentése levofloxacin belélegzése útján
US8168597B2 (en) 2008-10-22 2012-05-01 Inspire Pharmaceuticals, Inc. Method for treating cystic fibrosis
AU2010289326B2 (en) 2009-09-04 2015-09-24 Horizon Therapeutics U.S. Holding Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US9393243B1 (en) 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
WO2018074880A2 (ko) * 2016-10-20 2018-04-26 한국화학연구원 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033157A1 (de) 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3525335A1 (de) * 1985-07-16 1987-01-22 Bayer Ag Embonate von chinoloncarbonsaeuren und ihren derivaten
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE19812160C1 (de) * 1998-03-20 1999-07-08 Bayer Ag Formkörper aus wirkstoffhaltigen thermoplastischen Polyurethanen
WO2000015207A2 (en) * 1998-09-15 2000-03-23 Naeja Pharmaceutical Inc. Combination for the treatment of inflammation using elastine inhibitor(s) and antibacterial agent(s)
WO2001032144A1 (en) * 1999-10-29 2001-05-10 Inhale Therapeutic Systems, Inc. Dry powder compositions having improved dispersivity
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
US20030224039A1 (en) * 2002-03-05 2003-12-04 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
AU2003226567A1 (en) * 2002-04-25 2003-11-10 Nektar Therapeutics Uk Ltd Particulate materials
BRPI0407368A (pt) * 2003-02-10 2006-02-14 Bayer Healthcare Ag tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.

Also Published As

Publication number Publication date
NO20054180D0 (no) 2005-09-08
PE20050189A1 (es) 2005-05-22
US20120010215A1 (en) 2012-01-12
UY28179A1 (es) 2004-09-30
WO2004069253A1 (de) 2004-08-19
HRP20050786A2 (en) 2006-10-31
TW200503716A (en) 2005-02-01
IL170027A (en) 2012-02-29
CA2515262C (en) 2013-09-03
MA27632A1 (fr) 2005-11-01
AU2004210399A1 (en) 2004-08-19
MY144714A (en) 2011-10-31
AR043117A1 (es) 2005-07-20
SI1594500T1 (sl) 2011-02-28
JP2011173929A (ja) 2011-09-08
AU2004210399B2 (en) 2010-02-18
DK1594500T3 (da) 2011-01-24
DE502004011696D1 (de) 2010-11-11
EP1594500B1 (de) 2010-09-29
PT1594500E (pt) 2010-12-17
US20040254194A1 (en) 2004-12-16
HRP20050786B1 (hr) 2015-01-02
BRPI0407368A (pt) 2006-02-14
US8034817B2 (en) 2011-10-11
TWI347843B (en) 2011-09-01
NO331524B1 (no) 2012-01-23
ECSP055959A (es) 2006-01-16
JP2006517210A (ja) 2006-07-20
RU2005128132A (ru) 2006-02-10
EP1594500A1 (de) 2005-11-16
NZ541681A (en) 2009-02-28
KR20050098309A (ko) 2005-10-11
ATE482706T1 (de) 2010-10-15
MXPA05008407A (es) 2005-10-05
NO20054180L (no) 2005-09-08
RU2373937C2 (ru) 2009-11-27
RU2373937C9 (ru) 2010-07-27
KR101173696B1 (ko) 2012-08-13
JP4828405B2 (ja) 2011-11-30
HK1089380A1 (en) 2006-12-01
CA2515262A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
CY1110998T1 (el) Θεραπεια βακτηριακων ασθενειων των αναπνευστικων οργανων με τοπικη εφαρμογη φθοροκινολονων
CY1118137T1 (el) Αερολυμενες φθοροκινολονες και χρησεις αυτων
CY1115952T1 (el) Παραγωγα πυραζολο πυριδινης σαν αναστολεις της οξειδασης nadρη
CY1116315T1 (el) Παραγωγα κιναζολιν-4(3η)-ονης που χρησιμοποιουνται ως αναστολεις κινασης ρι3
CY1116455T1 (el) Υποκατεστημενα 4-αρυλο-1,4-διυδρο-1,6-ναφθυριδιν αμιδια και η χρηση τους
EA201170521A1 (ru) Новые соединения
BR112013002957A2 (pt) composto de 1,4,5,6-tetrahidro-pirimidin-2-ilamina
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
NO20063821L (no) Kinolinderivater for anvendelse som mykobakterielle inhibitorer
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
UA107188C2 (uk) Карбоксамідні похідні хіназолінів або хінолінів та фармацевтична композиція на їх основі
ME01285A (me) Derivati dioksa-bicikl0[3.2.1]oktan-2,3,4-triola
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
NO20084328L (no) Nye forbindelser
ATE530526T1 (de) Lactam-substituierte dicarbonsäuren und ihre verwendung
ATE523510T1 (de) Substituierte 4-aryl-1,4-dihydro-1,6- naphthyridine und ihre verwendung
EA201792597A2 (ru) Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
MA32723B1 (fr) Derives d'anilino-pyrimidine a substitution sulfoximine en tant qu'inhibiteurs de cdk, leur preparation et leur utilisation comme medicaments
MX350793B (es) Pirroldicarboxamidas condensadas y su uso como agentes farmaceuticos.
EA202190445A2 (ru) Раствор для перорального введения
MA32375B1 (fr) Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes
ATE380188T1 (de) Substituierte chinolone
ATE455789T1 (de) Substituierte nonadepsipeptide